| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.09. | Simply Solventless files Q2 financials, expects MCTO revocation | 1 | Investing.com | ||
| 01.09. | Simply Solventless Concentrates Ltd Q1 Loss Narrows | 2 | RTTNews | ||
| 31.08. | Simply Solventless Concentrates Ltd: Simply Solventless files Q1 2026 financials | 1 | Stockwatch | ||
| 28.08. | Simply Solventless Concentrates Ltd: Simply Solventless files 2025 results | 3 | Stockwatch | ||
| 27.08. | Simply Solventless Concentrates Ltd.: Simply Solventless Files 2025 Annual Financials and Provides Updates on Timing of Filing Q1 2026 Financials, Management Cease Trade Order, Private Placement and Debt Settlement | 837 | Newsfile | Not for distribution to U.S. news wire services or for dissemination in the United States.Calgary, Alberta--(Newsfile Corp. - August 27, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH)... ► Artikel lesen | |
| 24.08. | Simply Solventless Concentrates Ltd: Simply Solventless further delays 2025 results filing | 1 | Stockwatch | ||
| 22.08. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 1.233 | Newsfile | Calgary, Alberta--(Newsfile Corp. - August 22, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| SIMPLY SOLVENTLESS CONCENTRATES Aktie jetzt für 0€ handeln | |||||
| 15.08. | Simply Solventless Concentrates Ltd: Simply Solventless has no material changes | 1 | Stockwatch | ||
| 15.08. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 1.462 | Newsfile | Calgary, Alberta--(Newsfile Corp. - August 14, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 01.08. | Simply Solventless Concentrates Ltd: Simply Solventless delays 2025, Q1 2026 results filing | 3 | Stockwatch | ||
| 01.08. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 1.455 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 31, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 29.07. | Simply Solventless Concentrates Ltd.: Simply Solventless Announces CCAA Court Approvals, Secured Debt Amendments and Conversions to Equity, Strong Initial Humble Retrofit Results, Launch of $1.0M Private Placement of Units, and Executive Retirement | 611 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 28, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company") is pleased to announce (i) court approval of the transactions (the... ► Artikel lesen | |
| 22.07. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 856 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 21, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 08.07. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 571 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 7, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 06.07. | Simply Solventless Concentrates Ltd: Simply Solventless to file 2025 results July 17 | 1 | Stockwatch | ||
| 06.07. | Simply Solventless Concentrates Ltd: Simply Solventless has no material changes | 2 | Stockwatch | ||
| 04.07. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 1.225 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 4, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company") provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 19.06. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 727 | Newsfile | Calgary, Alberta--(Newsfile Corp. - June 18, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 12.06. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 601 | Newsfile | Calgary, Alberta--(Newsfile Corp. - June 11, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 29.05. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements, Q1 Financial Statements, Related Management's Discussion and Analysis and Management Cease Trade Order | 584 | Newsfile | Calgary, Alberta--(Newsfile Corp. - May 28, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company") provides an update regarding the filing of its audited annual financial... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 48,170 | -1,09 % | Nicht nur Bayer verdient am Weltmarkt mit, ohne überall selbst präsent zu sein: Ein australischer Psychedelika-Anbieter setzt auf dasselbe Grundprinzip | ||
| MERCK KGAA | 131,45 | -0,15 % | BARCLAYS stuft MERCK KGAA auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Merck KGaA von 140 auf 150 Euro angehoben, aber die Einstufung auf "Equal Weight" belassen. Analyst James Gordon... ► Artikel lesen | |
| YARROW BIOSCIENCE | 27,010 | 0,00 % | Yarrow Bioscience prices $150M public offering of common stock at $26 per share | ||
| BIODEXA PHARMACEUTICALS | 1,295 | -0,38 % | Biodexa Pharmaceuticals PLC: Interim results for the six months ended June 30, 2026 | September 11, 2026 Biodexa Pharmaceuticals PLC("Biodexa" or the "Company") Interim results for the six months ended June 30, 2026 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical... ► Artikel lesen | |
| NOVO NORDISK | 37,045 | -0,15 % | Novo Nordisk machte GLP-1 zum Milliardenmarkt, CAR-T die Krebsmedizin - welche Biotech-Plattform kommt als Nächstes? | ||
| AQUESTIVE THERAPEUTICS | 4,775 | -0,10 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update | Successfully completed human factors validation study and pharmacokinetic study for Anaphylm (dibutepinephrine) sublingual filmRemains on track to resubmit Anaphylm NDA to the FDA in Q3 2026Continues... ► Artikel lesen | |
| ELI LILLY | 962,10 | +0,06 % | Eli Lilly's (LLY) GLP-1 Growth Made It a Core "Running Back" Stock for Jim Cramer | ||
| DERMAPHARM | 37,400 | -2,35 % | JEFFERIES stuft Dermapharm auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Dermapharm nach einem Treffen mit dem Finanzchef Christof Dreibholz mit einem Kursziel von 44 Euro auf "Hold" belassen.... ► Artikel lesen | |
| SCHOTT PHARMA | 23,050 | -0,43 % | SCHOTT Pharma: Fair-Value-Signal führt zu 64 % Rendite | ||
| ETON PHARMACEUTICALS | 57,04 | -0,08 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DexCom, Oruka Therapeutics, Concentra Group Holdings Parent, AtaiBeckley | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 15,735 | +0,10 % | Generate Biomedicines auf Healthcare-Konferenz: Pipeline gewinnt an Fahrt | ||
| PFIZER | 23,845 | -0,21 % | Gewinner der Börsengeschichte: +3.923.693 % Rendite und ein Top ESG-Score? Ja, das geht! | © Foto: Frank Rumpenhorst - dpaNachhaltigkeit und eine hohe Rendite schließen sich nicht aus. Im Gegenteil: Diese ESG-Aktie schaffte es unter die Top 30 der US-Aktien mit der höchsten Buy-and-Hold-Rendite... ► Artikel lesen | |
| ASTRAZENECA | 137,45 | -0,51 % | Buy or Goodbye?: Meta, Apple, Rheinmetall und Astrazeneca - Die Analystenstimmen des Tages | © Foto: Julian Stratenschulte/dpa Meta, Apple, Rheinmetall und Astrazeneca: Die wichtigsten Analysten-Updates im Überblick Enthaltene Werte: US0378331005,DE0007030009,GB0009895292,US30303M1027Den vollständigen... ► Artikel lesen | |
| LB PHARMACEUTICALS | 44,600 | -0,07 % | LB Pharmaceuticals Appoints Joseph Miller As Chief Financial Officer | ||
| KARDIGAN | 18,600 | +0,43 % | Kardigan auf Cantor-Konferenz: Plattformansatz für Herzmedikamente |